Membership Directory

Children's Hospital Boston, Intellectual Property Office

Category: Academic, University & NonProfit Research Institutions
Phone: 617-355-7050
Fax: 617-730-0146
Website: http://www.childrenshospital.org/ipo

Children’s Hospital Boston (CHB) is the world’s premier pediatric academic medical center, and is affiliated with Harvard Medical School and Howard Hughes Medical Institute. The institution has a research funding base of $105M annually supporting over 130 Principal Investigators. The opening of a new research facility in October 2003 expanded CHB’s laboratory space to 600,000 sq. ft. Areas of research expertise include Vascular Biology, Stem Cells, Neuroscience, Genomics, and Informatics. Specialty pediatric clinics include Adolescent Medicine, Oncology, Genetics, Diabetes, Neurosurgery, and Cardiology. The Intellectual Property Office (IPO) provides a gateway to Children’s Hospital Boston researchers and technologies in all major biomedical disciplines for both pediatric and adult markets. The IPO’s 16-person professional team has backgrounds in business, law, and academic and industrial research. The IPO team manages all transactions with industry from start-ups, licenses, and clinical trials to material transfers. Results to date include over 300 licenses, 10 products in clinical development, and 5 medical products on the market. FY2003 revenues were $12M. Technology Development Initiatives: The Pediatric market is generally underserved since companies often lack the vision and skill to develop medical products for this niche. The IPO is using creative partnering and fundraising strategies to finance and manage early stage development of pediatric specific technologies. The Pediatric Product Development Initiative is developing medical devices while the Pediatric Formulation Initiative is focusing on pediatric specific formulations of existing pharmaceuticals. Our newest initiative is being organized to partner with commercial entities, government, and non-governmental organizations in developing countries to advance vaccines and other low margin technologies that address significant world health needs.

Back to list

Recent Jobs